ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,364.66
0.22%
Dow Jones
39,050.50
0.42%
US Dollar vs MXN
18.07182
1.04%
Brent Oil
79.865
-0.02%
Bitcoin
71,431.67
0.94%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Scopus BioPharma Inc (SCPS)

  7. Scopus BioPharma Inc (SCPS) Noticias

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SCPS
FechaHoraFuenteTítuloSímboloCompañía
02/11/202308:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
28/06/202316:16Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
12/05/202316:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
28/04/202316:05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
14/04/202316:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
16/12/202205:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
02/12/202216:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
15/11/202216:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
10/11/202208:15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
18/10/202208:25GlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
05/05/202207:30GlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
01/04/202216:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
22/03/202219:30GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
20/01/202207:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
19/01/202205:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
10/01/202207:30GlobeNewswire Inc.Scopus BioPharma Provides Update Following Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
10/01/202207:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SCPSScopus BioPharma Inc
06/01/202206:00PR Newswire (US)DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSNASDAQ:SCPSScopus BioPharma Inc
05/01/202215:51Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SCPSScopus BioPharma Inc
04/01/202205:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SCPSScopus BioPharma Inc
17/12/202107:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCPSScopus BioPharma Inc
17/12/202107:00GlobeNewswire Inc.Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyNASDAQ:SCPSScopus BioPharma Inc
07/12/202116:24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SCPSScopus BioPharma Inc
07/12/202107:30GlobeNewswire Inc.Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardNASDAQ:SCPSScopus BioPharma Inc
06/12/202106:00PR Newswire (US)Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingNASDAQ:SCPSScopus BioPharma Inc
26/11/202116:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPSScopus BioPharma Inc
22/11/202107:00GlobeNewswire Inc.Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketNASDAQ:SCPSScopus BioPharma Inc
08/11/202107:00GlobeNewswire Inc.Scopus BioPharma Announces Adjournment of Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
06/10/202114:07Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:SCPSScopus BioPharma Inc
05/10/202107:45GlobeNewswire Inc.Scopus BioPharma to Present at the LD Micro Main EventNASDAQ:SCPSScopus BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:SCPS

Su Consulta Reciente

USOTC
CTNI
Citron (CE)
USOTC
DETRF
Deterra Royalties (PK)
BIT
UC5270
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados